跳至主要内容
临床试验/CTRI/2015/06/005951
CTRI/2015/06/005951已完成未知

Role of Rifampicin in reducing inflammation and neuronal damage in childhood bacterial meningitis: A pilot randomised controlled trial

PGIMER0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
发起方
PGIMER
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patients with clinical features of bacterial meningitis in the form of acute onset of fever ( < 1 week duration) and signs of CNS involvement such as convulsions, lethargy, altered sensorium, neck stiffness.
  • Laboratory criteria (Any one of the following)
  • o Positive CSF or Latex Agglutination Test (LAT) for H.influenzae, S.pneumoniae, and N.meningitidis
  • o >10 WBC/ml of CSF, with blood culture positive for any bacteria
  • o >100 WBC/ml with >50% polymorphonuclear cells and CSF glucose <50% of blood glucose
  • o >1000 WBC/ml of CSF with >75% polymorphonuclear cells

排除标准

  • Patients with features of raised ICP
  • Previously received antibiotics > 24 hours ,
  • Developmental delay,
  • Severe malnutrition
  • Previously documented immunodeficiency
  • Infected lumbar puncture site

研究者

发起方
PGIMER

相似试验